Immune modulation by regulatory T cells in Helicobacter pylori-Associated diseases

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 12, Issue 1, 2012, Pages 71-85

  Raghavan, Sukanya ^a   Quiding Järbrink, Marianne ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Gastric adenocarcinoma; Gastritis; Helicobacter pylori; Peptic ulcer disease; Regulatory T cell

Indexed keywords

5' NUCLEOTIDASE; CD39 ANTIGEN; CD86 ANTIGEN; CYCLIC AMP; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 35; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; VIRULENCE FACTOR;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; ENTERITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; INFECTION; INNATE IMMUNITY; LYMPHOID TISSUE; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PEPTIC ULCER; REGULATORY T LYMPHOCYTE; REVIEW; STOMACH ADENOCARCINOMA; STOMACH MUCOSA; TH17 CELL;

EID: 84857133830     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/187153012799278974     Document Type: Review

References (219)

1. Palmer, E. and Naeher, D. (2009) Affinity threshold for thymic selection through a T-cell receptor-co-receptor zipper. Nat. Rev. Immunol., 9, 207-213.
2. Wing, K. and Sakaguchi, S. (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol., 11, 7-13.
3. Sakaguchi, S.; Miyara, M.; Costantino, C. M. and Hafler, D. A. (2010) FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol., 10, 490-500.
4. Lio, C. W. and Hsieh, C. S. (2010) Becoming self-aware: the hymic education of regulatory T cells. Curr. Opin. Immunol., 23, 213-219.
5. Fontenot, J. D.; Gavin, M. A. and Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol., 4, 330-336.
6. Hori, S.; Nomura, T. and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057-1061.
7. Faria, A. M. and Weiner, H. L. (2005) Oral tolerance. Immunol. Rev., 206, 232-259.
8. Roncarolo, M. G.; Gregori, S.; Battaglia, M.; Bacchetta, R.; Fleischhauer, K. and Levings, M. K. (2006) Interleukin-10- secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev., 212, 28-50.
9. Groux, H.; O'Garra, A.; Bigler, M.; Rouleau, M.; Antonenko, S.; de Vries, J. E. and Roncarolo, M. G. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, 389, 737-742.
10. Moore, K. W.; de Waal Malefyt, R.; Coffman, R. L. and O'Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol., 19, 683-765.
11. Levings, M. K.; Gregori, S.; Tresoldi, E.; Cazzaniga, S.; Bonini, C. and Roncarolo, M. G. (2005) Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood, 105, 1162-1169.
12. Asiedu, C. K.; Goodwin, K. J.; Balgansuren, G.; Jenkins, S. M.; Le Bas-Bernardet, S.; Jargal, U.; Neville, D. M.Jr. and Thomas, J. M. (2005) Elevated T regulatory cells in long-term stable transplant tolerance in rhesus macaques induced by anti-CD3 immunotoxin and deoxyspergualin. J. Immunol., 175, 8060-8068.
13. Battaglia, M.; Stabilini, A.; Draghici, E.; Gregori, S.; Mocchetti, C.; Bonifacio, E. and Roncarolo, M. G. (2006) Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes, 55, 40-49.
14. Li, M. O. and Flavell, R. A. (2008) TGF-beta: a master of all T cell trades. Cell, 134, 392-404.
15. Zheng, S. G.; Gray, J. D.; Ohtsuka, K.; Yamagiwa, S. and Horwitz, D. A. (2002) Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J. Immunol., 169, 4183-4189.
16. Chen, W.; Jin, W.; Hardegen, N.; Lei, K. J.; Li, L.; Marinos, N.; McGrady, G. and Wahl, S. M. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med., 198, 1875-1886.
17. Fantini, M. C.; Becker, C.; Monteleone, G.; Pallone, F.; Galle, P. R. and Neurath, M. F. (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol., 172, 5149-5153.
18. Davidson, T. S.; DiPaolo, R. J.; Andersson, J. and Shevach, E. M. (2007) Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J. Immunol., 178, 4022-4026.
19. Maynard, C. L.; Harrington, L. E.; Janowski, K. M.; Oliver, J. R.; Zindl, C. L.; Rudensky, A. Y. and Weaver, C. T. (2007) Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol., 8, 931-941.
20. Stumhofer, J. S.; Silver, J. S.; Laurence, A.; Porrett, P. M.; Harris, T. H.; Turka, L. A.; Ernst, M.; Saris, C. J.; O'Shea, J. J. and Hunter, C. A. (2007) Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol., 8, 1363-1371.
21. Awasthi, A.; Carrier, Y.; Peron, J. P.; Bettelli, E.; Kamanaka, M.; Flavell, R. A.; Kuchroo, V. K.; Oukka, M. and Weiner, H. L. (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol., 8, 1380-1389.
22. Marie, J. C.; Liggitt, D. and Rudensky, A. Y. (2006) Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity, 25, 441-454.
23. Li, M. O.; Sanjabi, S. and Flavell, R. A. (2006) Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and - independent mechanisms. Immunity, 25, 455-471.
24. Read, S.; Malmstrom, V. and Powrie, F. (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med., 192, 295-302.
25. Wolf, A. M.; Wolf, D.; Steurer, M.; Gastl, G.; Gunsilius, E. and Grubeck-Loebenstein, B. (2003) Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res., 9, 606-612.
26. Wing, K.; Onishi, Y.; Prieto-Martin, P.; Yamaguchi, T.; Miyara, M.; Fehervari, Z.; Nomura, T. and Sakaguchi, S. (2008) CTLA- 4 control over Foxp3+ regulatory T cell function. Science, 322, 271-275.
27. Friedline, R. H.; Brown, D. S.; Nguyen, H.; Kornfeld, H.; Lee, J.; Zhang, Y.; Appleby, M.; Der, S. D.; Kang, J. and Chambers, C. A. (2009) CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J. Exp. Med., 206, 421-434.
28. Tivol, E. A.; Borriello, F.; Schweitzer, A. N.; Lynch, W. P.; Bluestone, J. A. and Sharpe, A. H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA- 4. Immunity, 3, 541-547.
29. Waterhouse, P.; Penninger, J. M.; Timms, E.; Wakeham, A.; Shahinian, A.; Lee, K. P.; Thompson, C. B.; Griesser, H. and Mak, T. W. (1995) Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4. Science, 270, 985-988.
30. Oderup, C.; Cederbom, L.; Makowska, A.; Cilio, C. M. and Ivars, F. (2006) Cytotoxic T lymphocyte antigen-4-dependent downmodulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression. Immunology, 118, 240-249.
31. Fallarino, F.; Grohmann, U.; Hwang, K. W.; Orabona, C.; Vacca, C.; Bianchi, R.; Belladonna, M. L.; Fioretti, M. C.; Alegre, M. L. and Puccetti, P. (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol., 4, 1206-1212.
32. Misra, N.; Bayry, J.; Lacroix-Desmazes, S.; Kazatchkine, M.D. and Kaveri, S. V. (2004) Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol., 172, 4676-4680.
33. Tang, Q.; Adams, J. Y.; Tooley, A. J.; Bi, M.; Fife, B. T.; Serra, P.; Santamaria, P.; Locksley, R. M.; Krummel, M. F. and Bluestone, J. A. (2006) Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol., 7, 83-92.
34. Tadokoro, C. E.; Shakhar, G.; Shen, S.; Ding, Y.; Lino, A. C.; Maraver, A.; Lafaille, J. J. and Dustin, M. L. (2006) Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med., 203, 505-511.
35. Grossman, W. J.; Verbsky, J. W.; Barchet, W.; Colonna, M.; Atkinson, J. P. and Ley, T. J. (2004) Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity, 21, 589-601.
36. Grossman, W. J.; Verbsky, J. W.; Tollefsen, B. L.; Kemper, C.; Atkinson, J. P. and Ley, T. J. (2004). Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood, 104, 2840-2848.
37. Gondek, D. C.; Lu, L. F.; Quezada, S. A.; Sakaguchi, S. and Noelle, R. J. (2005) Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol., 174, 1783-1786.
38. Cao, X.; Cai, S. F.; Fehniger, T. A.; Song, J.; Collins, L. I.; Piwnica-Worms, D. R. and Ley, T. J. (2007) Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity, 27, 635-646.
39. Borsellino, G.; Kleinewietfeld, M.; Di Mitri, D.; Sternjak, A.; Diamantini, A.; Giometto, R.; Hopner, S.; Centonze, D.; Bernardi, G.; Dell'Acqua, M. L.; Rossini, P. M.; Battistini, L.; Rotzschke, O. and Falk, K. (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood, 110, 1225-1232.
40. Gavin, M. A.; Rasmussen, J. P.; Fontenot, J. D.; Vasta, V.; Manganiello, V. C.; Beavo, J. A. and Rudensky, A. Y. (2007) Foxp3-dependent programme of regulatory T-cell differentiation. Nature, 445, 771-775.
41. Fletcher, J. M.; Lonergan, R.; Costelloe, L.; Kinsella, K.; Moran, B. O'Farrelly, C.; Tubridy, N. and Mills, K. H. (2009) CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J. Immunol., 183, 7602-7610.
42. Deaglio, S.; Dwyer, K. M.; Gao, W.; Friedman, D.; Usheva, A.; Erat, A.; Chen, J. F.; Enjyoji, K.; Linden, J.; Oukka, M.; Kuchroo, V. K.; Strom, T. B. and Robson, S. C. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med., 204, 1257-1265.
43. Mandapathil, M.; Hilldorfer, B.; Szczepanski, M. J.; Czystowska, M.; Szajnik, M.; Ren, J.; Lang, S.; Jackson, E. K.; Gorelik, E. and Whiteside, T. L. (2010) Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J. Biol. Chem., 285, 7176-7186.
44. Stagg, J. and Smyth, M. J. (2010) Extracellular adenosine triphosphate and adenosine in cancer. Oncogene, 29, 5346-5358.
45. Ernst, P. B.; Garrison, J. C. and Thompson, L. F. (2010) Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J. Immunol., 185, 1993-1998.
46. Hoskin, D. W.; Mader, J. S.; Furlong, S. J.; Conrad, D. M. and Blay, J. (2008) Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Int. J. Oncol., 32, 527-535.
47. Bopp, T.; Becker, C.; Klein, M.; Klein-Hessling, S.; Palmetshofer, A.; Serfling, E.; Heib, V.; Becker, M.; Kubach, J.; Schmitt, S.; Stoll, S.; Schild, H.; Staege, M. S.; Stassen, M.; Jonuleit, H. and Schmitt, E. (2007) Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med., 204, 1303-1310.
48. Fassbender, M.; Gerlitzki, B.; Ullrich, N.; Lupp, C.; Klein, M.; Radsak, M. P.; Schmitt, E.; Bopp, T. and Schild, H. (2010) Cyclic adenosine monophosphate and IL-10 coordinately contribute to nTreg cell-mediated suppression of dendritic cell activation. Cell Immunol., 265, 91-96.
49. Cottrez, F.; Hurst, S. D.; Coffman, R. L. and Groux, H. (2000) T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol., 165, 4848-4853.
50. Pestka, S.; Krause, C. D.; Sarkar, D.; Walter, M. R.; Shi, Y. and Fisher, P. B. (2004) Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol., 22, 929-979.
51. Corinti, S.; Albanesi, C.; la Sala, A.; Pastore, S. and Girolomoni, G. (2001) Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol., 166, 4312-4318.
52. Brossart, P.; Zobywalski, A.; Grunebach, F.; Behnke, L.; Stuhler, G.; Reichardt, V. L.; Kanz, L. and Brugger, W. (2000) Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Cancer Res., 60, 4485-4492.
53. Maloy, K. J.; Salaun, L.; Cahill, R.; Dougan, G.; Saunders, N. J. and Powrie, F. (2003) CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med., 197, 111-119.
54. Shull, M. M.; Ormsby, I.; Kier, A. B.; Pawlowski, S.; Diebold, R. J.; Yin, M.; Allen, R.; Sidman, C.; Proetzel, G.; Calvin, D.; et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature, 359, 693-699.
55. Kulkarni, A. B.; Huh, C. G.; Becker, D.; Geiser, A.; Lyght, M.; Flanders, K. C.; Roberts, A. B.; Sporn, M. B.; Ward, J. M. and Karlsson, S. (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA, 90, 770-774.
56. Boivin, G. P.; Ormsby, I.; Jones-Carson, J.; O'Toole, B. A. and Doetschman, T. (1997) Germ-free and barrier-raised TGF beta 1- deficient mice have similar inflammatory lesions. Transgenic Res., 6, 197-202.
57. Thomas, D. A. and Massague, J. (2005) TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell, 8, 369-380.
58. Nakamura, K.; Kitani, A. and Strober, W. (2001) Cell contactdependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med., 194, 629-644.
59. Green, E. A.; Gorelik, L.; McGregor, C. M.; Tran, E. H. and Flavell, R. A. (2003) CD4+CD25+ T regulatory cells control antiislet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA, 100, 10878-10883.
60. Oida, T.; Zhang, X.; Goto, M.; Hachimura, S.; Totsuka, M.; Kaminogawa, S. and Weiner, H. L. (2003) CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism. J. Immunol., 170, 2516-2522.
61. Piccirillo, C. A.; Letterio, J. J.; Thornton, A. M.; McHugh, R. S.; Mamura, M.; Mizuhara, H. and Shevach, E. M. (2002) CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med., 196, 237-246.
62. Li, M. O.; Wan, Y. Y. and Flavell, R. A. (2007) T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity, 26, 579-591.
63. Collison, L. W.; Workman, C. J.; Kuo, T. T.; Boyd, K.; Wang, Y.; Vignali, K. M.; Cross, R.; Sehy, D.; Blumberg, R. S. and Vignali, D. A. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 450, 566-569.
64. Yang, J.; Yang, M.; Htut, T. M.; Ouyang, X.; Hanidu, A.; Li, X.; Sellati, R.; Jiang, H.; Zhang, S.; Li, H.; Zhao, J.; Ting, A. T.; Mayer, L.; Unkeless, J. C.; Labadia, M. E.; Hodge, M.; Li, J. and Xiong, H. (2008) Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur. J. Immunol., 38, 1204-1214.
65. Collison, L. W.; Chaturvedi, V.; Henderson, A. L.; Giacomin, P. R.; Guy, C.; Bankoti, J.; Finkelstein, D.; Forbes, K.; Workman, C. J.; Brown, S. A.; Rehg, J. E.; Jones, M. L.; Ni, H. T.; Artis, D.; Turk, M. J. and Vignali, D. A. (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol., 11, 1093-1101.
66. Bardel, E.; Larousserie, F.; Charlot-Rabiega, P.; Coulomb-L'Hermine, A. and Devergne, O. (2008) Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J. Immunol., 181, 6898-6905.
67. Allan, S. E.; Song-Zhao, G. X.; Abraham, T.; McMurchy, A. N. and Levings, M. K. (2008) Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur. J. Immunol., 38, 3282-3289.
68. Seyerl, M.; Kirchberger, S.; Majdic, O.; Seipelt, J.; Jindra, C.; Schrauf, C. and Stockl, J. (2010) Human rhinoviruses induce IL- 35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur. J. Immunol., 40, 321-329.
69. Barnes, M. J. and Powrie, F. (2009) Regulatory T cells reinforce intestinal homeostasis. Immunity, 31, 401-411.
70. Schulz, O.; Jaensson, E.; Persson, E. K.; Liu, X.; Worbs, T.; Agace, W. W. and Pabs, O. (2009) Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J. Exp. Med., 206, 3101-3114.
71. Mucida, D.; Park, Y.; Kim, G.; Turovskaya, O.; Scott, I.; Kronenberg, M. and Cheroutre, H. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science, 317, 256-260.
72. Coombes, J. L.; Siddiqui, K. R.; Arancibia-Carcamo, C. V.; Hall, J.; Sun, C. M.; Belkaid, Y. and Powrie, F. (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med., 204, 1757-1764.
73. Benson, M. J.; Pino-Lagos, K.; Rosemblatt, M. and Noelle, J. (2007) All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of costimulation. J. Exp. Med., 204, 1765-1774.
74. Sun, C. M.; Hall, J. A.; Blank, R. B.; Bouladoux, N.; Oukka, M.; Mora, J. R. and Belkaid, Y. (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med., 204, 1775-1785.
75. Maynard, C. L.; Hatton, R. D.; Helms, W. S.; Oliver, J. R.; Stephensen, C. B. and Weaver, C. T. (2009) Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells. J. Exp. Med., 206, 343-357.
76. Iwata, M.; Hirakiyama, A.; Eshima, Y.; Kagechika, H.; Kato, C. and Song, S. Y. (2004) Retinoic acid imprints gut-homing specificity on T cells. Immunity, 21, 527-538.
77. Johansson-Lindbom, B.; Svensson, M.; Pabst, O.; Palmqvist, C.; Marquez, G.; Forster, R. and Agace, W. W. (2005) Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med., 202, 1063-1073.
78. Sellon, R. K.; Tonkonogy, S.; Schultz, M.; Dieleman, L. A.; Grenther, W.; Balish, E.; Rennick, D. M. and Sartor, R. B. (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin- 10-deficient mice. Infect. Immun., 66, 5224-5231.
79. Kullberg, M. C.; Ward, J. M.; Gorelick, P. L.; Caspar, P.; Hieny, S.; Cheever, A.; Jankovic, D. and Sher, A. (1998) Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun., 66, 5157-5166.
80. Berg, D. J.; Davidson, N.; Kuhn, R.; Muller, W.; Menon, S.; Holland, G.; Thompson-Snipes, L.; Leach, M. W. and Rennick, D. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest., 98, 1010-1020.
81. Kuhn, R.; Lohler, J.; Rennick, D.; Rajewsky, K. and Muller, W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 75, 263-274.
82. Asseman, C.; Mauze, S.; Leach, M. W.; Coffman, R. L. and Powrie, F. (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med., 190, 995-1004.
83. Biswas, P. S.; Pedicord, V.; Ploss, A.; Menet, E.; Leiner, I. and Pamer, E. G. (2007) Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. J. Immunol., 179, 4520-4528.
84. Roers, A.; Siewe, L.; Strittmatter, E.; Deckert, M.; Schluter, D.; Stenzel, W.; Gruber, A. D.; Krieg, T.; Rajewsky, K. and Muller, W. (2004) T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med., 200, 1289-1297.
85. Kearley, J.; Barker, J. E.; Robinson, D. S. and Lloyd, C. M. (2005) Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med., 202, 1539-1547.
86. Rubtsov, Y. P.; Rasmussen, J. P.; Chi, E. Y.; Fontenot, J.; Castelli, L.; Ye, X.; Treuting, P.; Siewe, L.; Roers, A.; Henderson, W. R.Jr.; Muller, W. and Rudensky, A. Y. (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity, 28, 546-558.
87. Joetham, A.; Takeda, K.; Taube, C.; Miyahara, N.; Matsubara, S.; Koya, T.; Rha, Y. H.; Dakhama, A. and Gelfand, E. W. (2007) Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J. Immunol., 178, 1433-1442
88. Annes, J. P.; Munger, J. S. and Rifkin, D. B. (2003) Making sense of latent TGFbeta activation. J. Cell Sci., 116, 217-224.
89. Yang, Z.; Mu, Z.; Dabovic, B.; Jurukovski, V.; Yu, D.; Sung, J.; Xiong, X. and Munger, J. S. (2007) Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J. Cell Biol., 176, 787-793.
90. Travis, M. A.; Reizis, B.; Melton, A. C.; Masteller, E.; Tang, Q.; Proctor, J. M.; Wang, Y.; Bernstein, X.; Huang, X.; Reichardt, L. F.; Bluestone, J. A. and Sheppard, D. (2007) Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature, 449, 361-365.
91. Cerutti, A. (2008) The regulation of IgA class switching. Nat. Rev. Immunol., 8, 421-434.
92. Wang, Y. H.; Gorvel, J. P.; Chu, Y. T.; Wu, J. J. and Lei, H. Y. (2010) Helicobacter pylori impairs murine dendritic cell responses to infection. PLoS One, 5, e10844.
93. Tanaka, H.; Yoshida, M.; Nishiumi, S.; Ohnishi, N.; Kobayashi, K.; Yamamoto, K.; Fujita, T.; Hatakeyama, M. and Azuma, T. (2010) The CagA protein of Helicobacter pylori suppresses the functions of dendritic cell in mice. Arch. Biochem. Biophys., 498, 35-42.
94. Kao, J. Y.; Zhang, M.; Miller, M. J.; Mills, J. C.; Wang, B.; Liu, M.; Eaton, K. A.; Zou, W.; Berndt, B. E.; Cole, T. S.; Takeuchi, T.; Owyang, S. Y. and Luther, J. (2010) Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology, 138, 1046-1054.
95. McGuirk, P.; McCann, C. and Mills, K. H. (2002) Pathogenspecific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med., 195, 221-231.
96. Van der Kleij, D.; Van Remoortere, A.; Schuitemaker, J. H.; Kapsenberg, M. L.; Deelder, A. M.; Tielens, A. G.; Hokke, C. H. and Yazdanbakhsh, M. (2002) Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAc beta 1-4(Fuc alpha 1-2Fuc alpha 1-3)GlcNAc. J. Infect. Dis., 185, 531-539.
97. Nicholas, J. (2005) Human gammaherpesvirus cytokines and chemokine receptors. J. Interferon. Cytokine Res., 25, 373-383.
98. Raftery, M. J.; Wieland, D.; Gronewald, S.; Kraus, A. A.; Giese, T. and Schonrich, G. (2004) Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J. Immunol., 173, 3383-3391.
99. Kaufmann, S. H.; Cole, S. T.; Mizrahi, V.; Rubin, E. and Nathan, C. (2005) Mycobacterium tuberculosis and the host response. J. Exp. Med., 201, 1693-1697.
100. Guyot-Revol, V.; Innes, J. A.; Hackforth, S.; Hinks, T. and Lalvani, A. (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med., 173, 803-810.
101. Hougardy, J. M.; Place, S.; Hildebrand, M.; Drowart, A.; Debrie, A. S.; Locht, C. and Mascart, F. (2007) Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am. J. Respir. Crit. Care Med., 176, 409-416.
102. Wergeland, I.; Assmus, J. and Dyrhol-Riise, A. M. (2011) T regulatory cells and immune activation in mycobacterium tuberculosis infection and the effect of preventive therapy. Scand. J. Immunol., 73, 234-242.
103. Kursar, M.; Koch, M.; Mittrucker, H. W.; Nouailles, G.; Bonhagen, K.; Kamradt, T. and Kaufmann, S. H. (2007) Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol., 178, 2661-2665.
104. Belkaid, Y.; Piccirillo, C. A.; Mendez, S.; Shevach, E. M. and Sacks, D. L. (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature, 420, 502-507.
105. Marshall, B. J. and Warren, J. R. (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet, 1, 1311-1315.
106. Blaser, M. J. (1990) Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J. Infect. Dis., 161, 626-633.
107. Ernst, P. B. and Gold, B. D. (2000) The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol., 54, 615-640.
108. Sugiyama, T. (2004) Development of gastric cancer associated with Helicobacter pylori infection. Cancer Chemother. Pharmacol., 54 Suppl 1, S12-S20.
109. Kivi, M. and Tindberg, Y. (2006) Helicobacter pylori occurrence and transmission: a family affair? Scand. J. Infect. Dis., 38, 407-417.
110. Bhuiyan, T. R.; Saha, A.; Lundgren, A.; Qadri, F. and Svennerholm, A. M. (2010) Immune responses to Helicobacter pylori infection in Bangladeshi children during their first two years of life and the association between maternal antibodies and onset of infection. J. Infect. Dis., 202, 1676-1684.
111. Mitchell, H. M. (2001) Epidemiology of Infection. In Harry LT Mobley, George L Mendz, and S. L. Hazell (ed.), Helicobacter pylori: Physiology and Genetics. American Society of Microbiology, Washington (DC).
112. Janzon, A.; Bhuiyan, T.; Lundgren, A.; Qadri, F.; Svennerholm, A. M. and Sjoling, A. (2009) Presence of high numbers of transcriptionally active Helicobacter pylori in vomitus from Bangladeshi patients suffering from acute gastroenteritis. Helicobacter, 14, 237-247.
113. Covacci, A.; Censini, S.; Bugnoli, M.; Petracca, R.; Burroni, D.; Macchia, G.; Massone, A.; Papini, E.; Xiang, Z.; Figura, N.; et al. (1993) Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA, 90, 5791-5795.
114. Backert, S.; Tegtmeyer, N. and Selbach, M. (2010) The versatility of Helicobacter pylori CagA effector protein functions: The master key hypothesis. Helicobacter, 15, 163-176.
115. Blaser, M. J. (1998) Helicobacter pylori and gastric diseases. BMJ, 316, 1507-1510.
116. Covacci, A.; Falkow, S.; Berg, D. E. and Rappuoli, R. (1997) Did the inheritance of a pathogenicity island modify the virulence of Helicobacter pylori? Trends Microbiol., 5, 205-208.
117. Segal, E. D.; Falkow, S. and Tompkins, L. S. (1996) Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc. Natl. Acad. Sci. USA, 93, 1259-1264.
118. Stein, M.; Rappuoli, R. and Covacci, A. (2001) The cag Pathogenicity Island. In Harry LT Mobley, George L Mendz, and S. L. Hazell (ed.), Helicobacter pylori: Physiology and Genetics. American Society of Microbiology, Washington (DC).
119. Kwok, T.; Zabler, D.; Urman, S.; Rohde, M.; Hartig, R.; Wessler, S.; Misselwitz, R.; Berger, J.; Sewald, N.; Konig, W. and Backert, S. (2007) Helicobacter exploits integrin for type IV secretion and kinase activation. Nature, 449, 862-866.
120. Viala, J.; Chaput, C.; Boneca, I. G.; Cardona, A.; Girardin, S. E.; Moran, A. P.; Athman, R.; Memet, S.; Huerre, M. R.; Coyle, A. J.; DiStefano, P. S.; Sansonetti, P. J.; Labigne, A.; Bertin, J.; Philpott, D. J. and Ferrero, R. L. (2004) Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol., 5, 1166-1174.
121. Cover, T. L. and Blaser, M. J. (1992) Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem., 267, 10570-10575.
122. Eaton, K. A.; Cover, T. L.; Tummuru, M. K.; Blaser, M. J. and Krakowka, S. (1997) Role of vacuolating cytotoxin in gastritis due to Helicobacter pylori in gnotobiotic piglets. Infect. Immun., 65, 3462-3464.
123. Telford, J. L.; Ghiara, P.; Dell'Orco, M.; Comanducci, M.; Burroni, D.; Bugnoli, M.; Tecce, M. F.; Censini, S.; Covacci, A.; Xiang, Z.; et al. (1994) Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med., 179, 1653-1658.
124. Boncristiano, M.; Paccani, S. R.; Barone, S.; Ulivieri, C.; Patrussi, L.; Ilver, D.; Amedei, A.; D'Elios, M. M.; Telford, J. L. and Baldari, C. T. (2003). The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J. Exp. Med., 198, 1887-1897.
125. Gebert, B.; Fischer, W.; Weiss, E.; Hoffmann, R. and Haas, R. (2003) Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science, 301, 1099-1102.
126. Sundrud, M. S.; Torres, V. J.; Unutmaz, D. and Cover, T. L. (2004) Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc. Natl. Acad. Sci. USA, 101, 7727-7732.
127. Schmees, C.; Prinz, C.; Treptau, T.; Rad, R.; Hengst, L.; Voland, P.; Bauer, S.; Brenner, L.; Schmid, R. M. and Gerhard, M. (2007) Inhibition of T-Cell Proliferation by Helicobacter pylori [gamma]- Glutamyl Transpeptidase. Gastroenterology, 132, 1820-1833.
128. Chevalier, C.; Thiberge, J.-M.; Ferrero, R. L. and Labigne, A. (1999) Essential role of Helicobacter pylori -glutamyltranspeptidase for the colonization of the gastric mucosa of mice. Mol. Microbiol., 31, 1359-1372.
129. McGovern, K. J.; Blanchard, T. G.; Gutierrez, J. A.; Czinn, S. J.; Krakowka, S. and Youngman, P. (2001) {gamma}-Glutamyltransferase is a Helicobacter pylori virulence factor but is not essential for colonization. Infect. Immun., 69, 4168-4173.
130. Lu, H.; Hsu, P. I.; Graham, D. Y. and Yamaoka, Y. (2005) Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology, 128, 833-848.
131. Argent, R. H.; Burette, A.; Miendje Deyi, V. Y. and Atherton, J. C. (2007) The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America. Clin. Infect. Dis., 45, 1204-1206.
132. Muotiala, A.; Helander, I. M.; Pyhala, L.; Kosunen, T. U. and Moran, A. P. (1992) Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun., 60, 1714-1716.
133. Lee, S. K.; Stack, A.; Katzowitsch, E.; Aizawa, S. I.; Suerbaum, S. and Josenhans, C. (2003) Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect., 5, 1345-1356.
134. Hansson, M.; Lundgren, A.; Elgbratt, K.; Quiding-Jarbrink, M.; Svennerholm, A. M. and Johansson, E. L. (2006) Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3beta) after exposure to Helicobacter pylori. Microbes Infect., 8, 841-850.
135. Kao, J. Y.; Rathinavelu, S.; Eaton, K. A.; Bai, L.; Zavros, Y.; Takami, M.; Pierzchala, A. and Merchant, J. L. (2006) Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defense. Am. J. Physiol. Gastrointest. Liver Physiol., 291, G73-G81.
136. Necchi, V.; Manca, R.; Ricci, V. and Solcia, E. (2009) Evidence for transepithelial dendritic cells in human H. pylori active gastritis. Helicobacter, 14, 208-222.
137. Wilson, K. T. and Crabtree, J. E. (2007) Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology, 133, 288-308.
138. Yamaoka, Y.; Kita, M.; Kodama, T.; Sawai, N.; Tanahashi, T.; Kashima, K. and Imanishi, J. (1998) Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut, 42, 609-617.
139. D'Elios, M. M.; Manghetti, M.; De Carli, M.; Costa, F.; Baldari, C. T.; Burroni, D.; Telford, J. L.; Romagnani, S. and Del Prete, G. (1997) T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol., 158, 962-967.
140. Lindholm, C.; Quiding-Jarbrink, M.; Lonroth, H.; Hamlet, A. and Svennerholm, A. M. (1998) Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun., 66, 5964-5971.
141. Lundgren, A.; Trollmo, C. Edebo, A. Svennerholm, A. M. and Lundin, B. S. (2005) Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa. Infect. Immun., 73, 5612-5619.
142. Mizuno, T.; Ando, T.; Nobata, K.; Tsuzuki, T.; Maeda, O.; Watanabe, O.; Minami, M.; Ina, K.; Kusugami, K.; Peek, R. M. and Goto, H. (2005) Interleukin-17 levels in Helicobacter pyloriinfected gastric mucosa and pathologic sequelae of colonization. World J. Gastroenterol., 11, 6305-6311.
143. Luzza, F.; Parrello, T.; Monteleone, G.; Sebkova, L.; Romano, M.; Zarrilli, R.; Imeneo, M. and Pallone, F. (2000) Up-regulation of IL17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol., 165, 5332-5337.
144. Zhang, M.; Liu, M.; Luther, J. and Kao, J. Y. (2010) Helicobacter pylori directs tolerogenic programming of dendritic cells. Gut Microbes, 1, 325-329.
145. Mitchell, P.; Germain, C.; Fiori, P. L.; Khamri, W.; Foster, G. R.; Ghosh, S.; Lechler, R. I.; Bamford, K. B. and Lombardi, G. (2007) Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect. Immun., 75, 810-819.
146. Bimczok, D.; Grams, J. M.; Stahl, R. D.; Waites, K. B.; Smythies, L. E. and Smith, P. D. (2011). Stromal regulation of human gastric dendritic cells restricts the Th1 response to H pylori. Gastroenterology, 141, 929-938.
147. Raghavan, S. and Holmgren, J. (2005) CD4+CD25+ suppressor T cells regulate pathogen induced inflammation and disease. FEMS Immunol. Med. Microbiol., 44, 121-127.
148. Martinez, F. O.; Helming, L. and Gordon, S. (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol., 27, 451-483.
149. Quiding-Jarbrink, M.; Raghavan, S. and Sundquist, M. (2010) Enhanced M1 macrophage polarization in human Helicobacter pylori-associated atrophic gastritis and in vaccinated mice. PLoS ONE, 5, e15018.
150. Satin, B.; Del Giudice, G.; Della Bianca, V.; Dusi, S.; Laudanna, C.; Tonello, F.; Kelleher, D.; Rappuoli, R.; Montecucco, C. and Rossi, F. (2000) The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med., 191, 1467-1476.
151. Brisslert, M.; Enarsson, K.; Lundin, S.; Karlsson, A.; Kusters, J. G.; Svennerholm, A. M.; Backert, S. and Quiding-Jarbrink, M. (2005) Helicobacter pylori induce neutrophil transendothelial migration: role of the bacterial HP-NAP. FEMS Microbiol. Lett., 249, 95-103.
152. Amedei, A.; Cappon, A.; Codolo, G.; Cabrelle, A.; Polenghi, A.; Benagiano, M.; Tasca, E.; Azzurri, A.; D'Elios, M. M.; Del Prete, G. and de Bernard, M. (2006) The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Invest., 116, 1092-1101.
153. Ismail, H. F.; Fick, P.; Zhang, J.; Lynch, R. G. and Berg, D. J. (2003) Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J. Immunol., 170, 3782-3789.
154. DeLyria, E. S.; Redline, R. W. and Blanchard, T. G. (2009) Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology, 136, 247-256.
155. Mattsson, A.; Quiding-Jarbrink, M.; Lonroth, H.; Hamlet, A.; Ahlstedt, I. and Svennerholm, A. (1998) Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect. Immun., 66, 2705-2712.
156. Hansson, M.; Hermansson, M.; Svensson, H.; Elfvin, A.; Hansson, L. E.; Johnsson, E.; Sjoling, A. and Quiding-Jarbrink, M. (2008) CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells. Infect. Immun., 76, 3304-3311.
157. Bogstedt, A. K.; Nava, S.; Wadstrom, T. and Hammarstrom, L. (1996) Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system. Clin. Exp. Immunol., 105, 202-204.
158. Blanchard, T. G.; Czinn, S. J.; Redline, R. W.; Sigmund, N.; Harriman, G. and Nedrud, J. G. (1999) Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell Immunol., 191, 74-80.
159. Akhiani, A. A.; Stensson, A.; Schon, K. and Lycke, N. Y. (2005) IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J. Immunol., 174, 8144-8153.
160. Akhiani, A. A.; Schon, K.; Franzen, L. E.; Pappo, J.; and Lycke, N. (2004) Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. J. Immunol., 172, 5024-5033.
161. Sayi, A.; Kohler, E.; Toller, I. M.; Flavell, R. A.; Muller, W.; Roers, A. and Muller, A. (2011) TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. J. Immunol., 186, 878-890.
162. Raghavan, S.; Svennerholm, A. M. and Holmgren, J. (2002) Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis. Infect. Immun., 70, 4621-4627.
163. Sutton, P.; Danon, S. J.; Walker, M.; Thompson, L. J.; Wilson, J.; Kosaka, T. and Lee, A. (2001) Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut, 49, 467-473.
164. Garhart, C. A.; Redline, R. W.; Nedrud, J. G. and Czinn, S. J. (2002) Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice. Infect. Immun., 70, 3529-3538.
165. Sawai, N.; Kita, M.; Kodama, T.; Tanahashi, T.; Yamaoka, Y.; Tagawa, Y.; Iwakura, Y. and Imanishi, J. (1999) Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect. Immun., 67, 279-285.
166. Akhiani, A. A.; Pappo, J.; Kabok, Z.; Schon, K.; Gao, W.; Franzen, L. E. and Lycke, N. (2002) Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J. Immunol., 169, 6977-6984.
167. Eaton, K. A.; Benson, L. H.; Haeger, J. and Gray, B. M. (2006) Role of transcription factor T-bet expression by CD4+ cells in gastritis due to Helicobacter pylori in mice. Infect. Immun., 74, 4673-4684.
168. Miossec, P.; Korn, T. and Kuchroo, V. K. (2009) Interleukin-17 and type 17 helper T cells. N. Engl. J. Med., 361, 888-898.
169. Lubberts, E.; Koenders, M. I. and van den Berg, W. B. (2005) The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther., 7, 29-37.
170. Langrish, C. L.; Chen, Y.; Blumenschein, W. M.; Mattson, J.; Basham, B.; Sedgwick, J. D.; McClanahan, T.; Kastelein, R. A. and Cua, D. J. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med., 201, 233-240.
171. Kullberg, M. C.; Jankovic, D.; Feng, C. G.; Hue, S.; Gorelick, P. L.; McKenzie, B. S.; Cua, D. J.; Powrie, F.; Cheever, A. W.; Maloy, K. J. and Sher, A. (2006) IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med., 203, 2485-94.
172. Bettelli, E.; Carrier, Y.; Gao, W.; Korn, T.; Strom, T. B.; Oukka, M.; Weiner, H. L. and Kuchroo, V. K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441, 235-238.
173. Veldhoen, M.; Hocking, R. J.; Atkins, C. J.; Locksley, R. M. and Stockinger, B. (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17- producing T cells. Immunity, 24, 179-189.
174. Khamri, W.; Walker, M. M.; Clark, P.; Atherton, J. C.; Thursz, M. R.; Bamford, K. B.; Lechler, R. I. and Lombardi, G. (2010) Helicobacter pylori stimulates dendritic cells to induce interleukin- 17 expression from CD4+ T lymphocytes. Infect. Immun., 78, 845-853.
175. Lundgren, A.; Stromberg, E.; Sjoling, A.; Lindholm, C.; Enarsson, K.; Edebo, A.; Johnsson, E.; Suri-Payer, E.; Larsson, P.; Rudin, A.; Svennerholm, A. M. and Lundin, B. S. (2005) Mucosal FOXP3- expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect. Immun., 73, 523-531.
176. Stromberg, E.; Edebo, A.; Lundin, B. S.; Bergin, P.; Brisslert, M.; Svennerholm, A. M. and Lindholm, C. (2005) Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors. Clin. Exp. Immunol., 140, 117-125.
177. Kandulski, A.; Wex, T.; Kuester, D.; Peitz, U.; Gebert, I.; Roessner, A. and Malfertheiner, P. (2008) Naturally occurring regulatory T cells (CD4+, CD25high, FOXP3+) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-beta1. Helicobacter, 13, 295-303.
178. Jang, T. J. (2010) The number of Foxp3-positive regulatory T cells is increased in Helicobacter pylori gastritis and gastric cancer. Pathol. Res. Pract., 206, 34-38.
179. Rad, R.; Brenner, L.; Bauer, S.; Schwendy, S.; Layland, L.; da Costa, C. P.; Reindl, W.; Dossumbekova, A.; Friedrich, M.; Saur, D.; Wagner, H.; Schmid, R. M. and Prinz, C. (2006) CD25+/ Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology, 131, 525-537.
180. Becher, D.; Deutscher, M. E.; Simpfendorfer, K. R.; Wijburg, O. L.; Pederson, J. S.; Lew, A. M.; Strugnell, R. A. and Walduck, A. K. (2010) Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice. Eur. J. Immunol., 40, 2778-2790.
181. Kindlund, B.; Sjoling, A.; Hansson, M.; Edebo, A.; Hansson, L. E.; Sjovall, H.; Svennerholm, A. M. and Lundin, B. S. (2009) FOXP3- expressing CD4(+) T-cell numbers increase in areas of duodenal gastric metaplasia and are associated to CD4(+) T-cell aggregates in the duodenum of Helicobacter pylori-infected duodenal ulcer patients. Helicobacter, 14, 192-201.
182. Flach, C. F.; Ostberg, A. K.; Nilsson, A. T.; Malefyt Rde, W. and Raghavan, S. (2011) Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase. Infect. Immun., 79, 879-886.
183. Velin, D.; Favre, L.; Bernasconi, E.; Bachmann, D.; Pythoud, C.; Saiji, E.; Bouzourene, H. and Michetti, P. (2009) Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model. Gastroenterology, 136, 2237-2246 e1.
184. Raghavan, S.; Fredriksson, M.; Svennerholm, A. M.; Holmgren, J. and Suri-Payer, E. (2003) Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin. Exp. Immunol., 132, 393-400.
185. Kaparakis, M.; Laurie, K. L.; Wijburg, O.; Pedersen, J.; Pearse, M.; van Driel, I. R.; Gleeson, P. A. and Strugnell, R. A. (2006) CD4+ CD25+ regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice. Infect. Immun., 74, 3519-3529.
186. Anderson, K. M.; Czinn, S. J.; Redline, R. W. and Blanchard, T. G. (2006) Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection. J. Immunol., 176, 5306-5313.
187. Matsumoto, Y.; Blanchard, T. G.; Drakes, M. L.; Basu, M.; Redline, R. W.; Levine, A. D. and Czinn, S. J. (2005) Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice. Helicobacter, 10, 407-415.
188. Chen, W.; Shu, D. and Chadwick, V. S. (2001) Helicobacter pylori infection: mechanism of colonization and functional dyspepsia Reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin-10. J. Gastroenterol. Hepatol., 16, 377-383.
189. Lee, C. W.; Rao, V. P.; Rogers, A. B.; Ge, Z.; Erdman, S. E.; Whary, M. T. and Fox, J. G. (2007) Wild-type and interleukin-10- deficient regulatory T cells reduce effector T-cell-mediated gastroduodenitis in Rag2-/- mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis. Infect. Immun., 75, 2699-2707.
190. Hitzler, I.; Oertli, M.; Becher, B.; Agger, E. M. and Muller, A. (2011) Dendritic cells prevent rather than promote immunity conferred by a helicobacter vaccine using a mycobacterial adjuvant. Gastroenterology, 141, 186-196.e1.
191. Alam, M. S.; Kurtz, C. C.; Rowlett, R. M.; Reuter, B. K.; Wiznerowicz, E.; Das, S.; Linden, J.; Crowe, S. E. and Ernst, P. B. (2009) CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J. Infect. Dis., 199, 494-504.
192. Lundgren, A.; Suri-Payer, E.; Enarsson, K.; Svennerholm, A. M. and Lundin, B. S. (2003) Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun., 71, 1755-1762.
193. Enarsson, K.; Lundgren, A.; Kindlund, B.; Hermansson, M.; Roncador, G.; Banham, A. H.; Lundin, B. S. and Quiding-Jarbrink, M. (2006) Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin. Immunol., 121, 358-368.
194. Kobayashi, M.; Mitoma, J.; Nakamura, N.; Katsuyama, T.; Nakayama, J. and Fukuda, M. (2004) Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. Proc. Natl. Acad. Sci. USA, 101, 17807-17812.
195. Harris, P. R.; Wright, S. W.; Serrano, C.; Riera, F.; Duarte, I.; Torres, J.; Pena, A.; Rollan, A.; Viviani, P.; Guiraldes, E.; Schmitz, J. M.; Lorenz, R. G.; Novak, L.; Smythies, L. E. and Smith, P. D. (2008) Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology, 134, 491-499.
196. Olbe, L.; Fandriks, L.; Hamlet, A.; Svennerholm, A. M. and Thoreson, A. C. (2000) Mechanisms involved in Helicobacter pylori induced duodenal ulcer disease:an overview. World J. Gastroenterol., 6, 619-623.
197. Hamlet, A.; Thoreson, A. C.; Nilsson, O.; Svennerholm, A. M. and Olbe, L. (1999) Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology, 116, 259-268.
198. Stromberg, E.; Edebo, A.; Svennerholm, A. M. and Lindholm, C. (2003) Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients. Clin. Diagn. Lab Immunol., 10, 116-124.
199. Robinson, K.; Kenefeck, R.; Pidgeon, E. L.; Shakib, S.; Patel, S.; Polson, R. J.; Zaitoun, A. M. and Atherton, J. C. (2008) Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut, 57, 1375-1385.
200. Teng, M. W.; Swann, J. B.; von Scheidt, B.; Sharkey, J.; Zerafa, N.; McLaughlin, N.; Yamaguchi, T.; Sakaguchi, S.; Darcy, P. K. and Smyth, M. J. (2010) Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion. Cancer Res., 70, 2665-2674.
201. Li, X.; Kostareli, E.; Suffner, J.; Garbi, N. and Hammerling, G. J. (2010) Efficient Treg depletion induces T-cell infiltration and rejection of large tumors. Eur. J. Immunol., 40, 3325-3335.
202. Curiel, T. J.; Coukos, G.; Zou, L.; Alvarez, X.; Cheng, P.; Mottram, P.; Evdemon-Hogan, M.; Conejo-Garcia, J. R.; Zhang, L.; Burow, M.; Zhu, Y.; Wei, S.; Kryczek, I.; Daniel, B.; Gordon, A.; Myers, L.; Lackner, A.; Disis, M. L.; Knutson, K. L.; Chen, L. and Zou, W. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med., 10, 942-949.
203. Kobayashi, N.; Hiraoka, N.; Yamagami, W.; Ojima, H.; Kanai, Y.; Kosuge, T.; Nakajima, A. and Hirohashi, S. (2007) FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin. Cancer Res., 13, 902-911.
204. Petersen, R. P.; Campa, M. J.; Sperlazza, J.; Conlon, D.; Joshi, M. B.; Harpole, D. H. Jr. and Patz, E. F.Jr. (2006) Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer, 107, 2866-2872.
205. Mizukami, Y.; Kono, K.; Kawaguchi, Y.; Akaike, H.; Kamimura, K.; Sugai, H. and Fujii, H. (2008) Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer. Br. J. Cancer, 98, 148-153.
206. Shen, Z.; Zhou, S.; Wang, Y.; Li, R. L.; Zhong, C.; Liang, C. and Sun, Y. (2010) Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J. Cancer Res. Clin. Oncol., 136, 1585-1595.
207. Enarsson, K.; Johnsson, E.; Lindholm, C.; Lundgren, A.; Pan-Hammarstrom, Q.; Stromberg, E.; Bergin, P.; Baunge, E. L.; Svennerholm, A. M. and Quiding-Jarbrink, M. (2006) Differential mechanisms for T lymphocyte recruitment in normal and neoplastic human gastric mucosa. Clin. Immunol., 118, 24-34.
208. Yuan, X. L.; Chen, L.; Li, M. X.; Dong, P.; Xue, J.; Wang, J.; Zhang, T. T.; Wang, X. A.; Zhang, F. M.; Ge, H. L.; Shen, L. S. and Xu, D. (2010) Elevated expression of Foxp3 in tumorinfiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin. Immunol., 134, 277-288.
209. Lundin, B. S.; Enarsson, K.; Kindlund, B.; Lundgren, A.; Johnsson, E.; Quiding-Järbrink, M. and Svennerholm, A.-M. (2007) The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin-10. Clin. Immunol., 125, 205-213.
210. Watanabe, T.; Tada, M.; Nagai, H.; Sasaki, S. and Nakao, M. (1998) Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology, 115, 642-648.
211. Elfvin, A.; Bolin, I.; Von Bothmer, C.; Stolte, M.; Watanabe, H.; Fandriks, L. and Vieth, M. (2005) Helicobacter pylori induces gastritis and intestinal metaplasia but no gastric adenocarcinoma in Mongolian gerbils. Scand. J. Gastroenterol., 40, 1313-1320.
212. Lee, C. W.; Rickman, B.; Rogers, A. B.; Ge, Z.; Wang, T. C. and Fox, J. G. (2008) Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res., 68, 3540-3548.
213. Fox, J. G.; Rogers, A. B.; Whary, M. T.; Ge, Z.; Ohtani, M.; Jones, E. K. and Wang, T. C. (2007) Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 -/- C57BL6 x Sv129 Helicobacter pylori-infected mice. Am. J. Pathol., 171, 1520-1528.
214. Sayi, A.; Kohler, E.; Hitzler, I.; Arnold, I.; Schwendener, R.; Rehrauer, H. and Muller, A. (2009) The CD4+ T cell-mediated IFN-gamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk. J. Immunol., 182, 7085-7101.
215. Arnold, I. C.; Lee, J. Y.; Amieva, M. R.; Roers, A.; Flavell, R. A.; Sparwasser, T. and Muller, A. (2011) Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology, 140, 199-209.
216. Peggs, K. S.; Quezada, S. A.; Korman, A. J. and Allison, J. P. (2006) Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Curr. Opin. Immunol., 18, 206-213.
217. Cao, Y.; Zhao, J.; Yang, Z.; Cai, Z.; Zhang, B.; Zhou, Y.; Shen, G.- X.; Chen, X.; Li, S. and Huang, B. (2010) CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy. Clin. Immunol., 136, 21-29.
218. Dillman, R. O. (2011) Cancer Immunotherapy. Cancer Biother. Radiopharma., 26, 1-64.
219. Sakaguchi, S.; Sakaguchi, N.; Asano, M.; Itoh, M. and Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 155, 1151-1164.